Jérémie N’Gouan: Challenges and Vision for the Future of Côte d’Ivoire
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, mentions some of the challenges to be faced by the institution.
Pigier Côte d’Ivoire: Partnerships and Expansion Plans
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, mentions some partnership opportunities and shares his goals for the coming years.
Education in Côte d’Ivoire: Advantages and Differentials of Pigier
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, explains what are the main advantages and differentials of the institution, mentioning the importance of maintaining high quality education.
Overview of the Higher Education System in Côte d’Ivoire
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, gives his evaluation of the higher education system in Côte d’Ivoire, saying that in the last few years, the private sector has become increasingly important.
Cipharm – Fabricant Numéro 1 de Produits Pharmaceutiques en Côte d’Ivoire
Profil de Cipharm, une entreprise ivoirienne devenue le fabriquant numéro 1 de produits pharmaceutiques en Côte d’Ivoire depuis sa création en 1988.
Transport de Marchandises: Partenariat entre SIMAT et NileDutch
La Société Ivoirienne de Manutention et de Transit (SIMAT) entend passer de prestataire en manutention et logistique à leader dans la chaine d’approvisionnement grâce à un partenariat avec NileDutch, la ligne maritime Néerlandaise.
Overview of SIMAT: Société Ivoirienne de Manutention et de Transit
Stéphane Eholie, Chief Executive Officer of SIMAT (Société Ivoirienne de Manutention et de Transit)
Stéphane Eholie gives an evaluation of the logistics sector, mentioning the competition, SIMAT’s differentials, the areas to be developped and the importance of quality and social responsibility. Mr Eholie also shares his vision for the future of Côte d’Ivoire in the coming years.
Ibrahim Diawara: Competitive Advantage and Vision for Cipharm
Ibrahim Diawara, President and CEO of Cipharm, explains why a foreign investor interested in coming to Côte d’Ivoire should invest within the company. Mr Diawara also shares his vision for Cipharm in the coming years.
Côte d’Ivoire Pharmaceutical Industry: Challenges of Cipharm
Ibrahim Diawara talks about the challenges of Cipharm and the pharmaceutical industry as a whole in Côte d’Ivoire, mentioning the problem of strong competition coming from imported products by famous international pharmaceutical groups.
Cipharm Côte d’Ivoire: Plans and Investment Opportunities
Ibrahim Diawara, President and CEO of Cipharm, gives an overview of the company’s future plans of launching a third unit to produce injectable medicines and doubling its turnover by 2020. Mr Diawara also talks about investment opportunities within Cipharm, saying that the company is open to offers from investors.